Figure 2. AR expression according to breast cancer subtype. AR positivity differed in breast cancer subtypes. AR positivity was more common in luminal subtypes than in HER2-positive or triple-negative breast cancer types.

AR = androgen receptor; HER2 = human epidermal growth factor receptor 2.